Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03423108 |
Date of registration:
|
31/01/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Exercise Dose-response for Diabetes in the Elderly
EDDIE |
Scientific title:
|
Exercise Dose-response for Diabetes in the Elderly: a Randomized Clinical Trial. |
Date of first enrolment:
|
September 10, 2018 |
Target sample size:
|
132 |
Recruitment status: |
Unknown status |
URL:
|
https://clinicaltrials.gov/show/NCT03423108 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Brazil
| | | | | | | |
Contacts
|
Name:
|
Daniel Umpierre, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital de Clinicas de Porto Alegre/Federal University of Rio Grande do Sul |
|
Name:
|
Angélica De Nardi, MSc |
Address:
|
|
Telephone:
|
+55 51 3359-6332 |
Email:
|
atnardi@hcpa.edu.br |
Affiliation:
|
|
|
Name:
|
Angélica De Nardi, MSc |
Address:
|
|
Telephone:
|
+55 51 3359-6332 |
Email:
|
atnardi@hcpa.edu.br |
Affiliation:
|
|
|
Name:
|
Beatriz Schaan, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hospital de Clinicas de Porto Alegre/Federal University of Rio Grande do Sul |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Previous diagnosis of type 2 diabetes mellitus by HbA1c (> 6.5%) or capillary casual
glycemia (> 126 mg/dL), oral glucose tolerance test or hypoglycemic drug use;
- HbA1c = 7.5%;
- Verified ability to exercise;
- Physically inactive or regularly exercising for at least once a week.
Exclusion Criteria:
- HbA1c = 12%;
- Severe cardiovascular disease (class III or IV heart failure, uncontrolled arrhythmia,
unstable angina, or use of implantable cardioverter defibrillator);
- Major cardiovascular events 1 year previously to the enrollment (non-fatal myocardial
infarction, coronary artery bypass surgery, cardiac catheterization, deep vein
thrombosis, hospitalization or other severe health-related event);
- Chronic renal disease requesting dialysis;
- Severe macular injury (retinopathy) that disables patients to enroll an exercise
program;
- Severe cognitive impairment (dementia) that disables patients to enroll an exercise
program;
- Deafness that disables patients to enroll an exercise program;
- Blindness that disables patients to enroll an exercise program;
- Progressive neurological disorders (Parkinson, multiple sclerosis, etc.) that disables
patients to enroll an exercise program;
- Osteoarticular or muscular injuries or another health conditions which generate
inability to carry on the interventions;
- Plans of moving to another city during the study;
- Living together with another person enrolled in the study;
- A medical report indicating exercise contraindication based on a cardiopulmonary
exercise testing;
- Inability or refusal to give written consent.
Age minimum:
60 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Type2 Diabetes
|
Intervention(s)
|
Behavioral: G300
|
Behavioral: G150
|
Primary Outcome(s)
|
HbA1c
[Time Frame: Change from baseline to 24 weeks]
|
Secondary Outcome(s)
|
Cardiorespiratory fitness
[Time Frame: Change from baseline to 24 weeks]
|
Endothelial function
[Time Frame: Change from baseline to 24 weeks]
|
Office Blood Pressure
[Time Frame: Change from baseline to 12 weeks]
|
Body composition
[Time Frame: Change from baseline to 24 weeks]
|
Lower body maximal muscle strength
[Time Frame: Change from baseline to 24 weeks]
|
Geriatric Depression Symptoms
[Time Frame: Change from baseline to 24 weeks]
|
HbA1c
[Time Frame: Change from baseline to 12 weeks]
|
Intima-media thickness
[Time Frame: Change from baseline to 24 weeks]
|
Lower limbs functional capacity
[Time Frame: Change from baseline to 24 weeks]
|
Muscle thickness
[Time Frame: Change from baseline to 24 weeks]
|
Muscle quality
[Time Frame: Change from baseline to 24 weeks]
|
Quality of life (QoL)
[Time Frame: Change from baseline to 24 weeks]
|
Endothelial function, early adaptation
[Time Frame: Change from baseline to 12 weeks]
|
Office Blood Pressure
[Time Frame: Change from baseline to 24 weeks]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|